Skip to Content

'
Anthony P. Conley, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Holcombe Blvd.
Unit Number: 450
Houston, TX 77030
Room Number: FC12.3032
Phone: 713-792-3626
Fax: 713-794-1934
Email: aconley@mdanderson.org

Education & Training

Degree-Granting Education

2004 The University of Texas, Medical Branch, Galveston, TX, MD, Doctor of Medicine
2000 The University of Texas, Pan American, Edinburg, TX, BS, Biology

Postgraduate Training

7/2007-6/2010 Clinical Fellowship, Medical Oncology, The The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Wolff
7/2005-6/2007 Clinical Residency, The University of Texas Health Science Center, Houston, TX, Dr. Farnie
6/2004-6/2005 Clinical Internship, The University of Texas Health Science Center, Houston, TX

Board Certifications

8/2007 American Board of Internal Medicine

Honors and Awards

2010 ASCO Cancer Foundation Young Invstigator Award, ASCO
2007 Michelle Miller Rozzell Academic Achievement Award, The University of Texas, Houston
2007 Outstanding Resident of the Year Award, The University of Texas, Houston

Selected Publications

Peer-Reviewed Original Research Articles

1. de la Fuente SG, Deneve JL, Parsons CM, Zager JS, Conley AP, Gonzalez RJ. A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis. HPB (Oxford) 15(9):655-60, 9/2013. e-Pub 12/2012. PMID: 23458233.
2. Amankwah EK, Conley AP, Reed DR. Epidemiology and therapies fo metastatic sarcoma. Clinical Epidemiology, 5/2013.
3. Jardim DL, Conley A, Subbiah V. Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities. Orphanet J Rare Dis 8(1):112, 2013. e-Pub 7/2013. PMCID: PMC3751902.
4. Amankwah EK, Conley AP, Reed DR. Epidemiology and therapies for metastatic sarcoma. Clin Epidemiol 5:147-62, 2013. e-Pub 5/2013. PMCID: PMC3660127.
5. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7, 2013. e-Pub 5/2013. PMCID: PMC3660184.
6. Vohra NA, Turaga KK, Gonzalez RJ, Conley A, Reed D, Bui MM, Cheong D, Letson DG, Zager JS. The use of isolated limb infusion in limb threatening extremity sarcomas. Int J Hyperthermia 29(1):1-7, 2013. e-Pub 12/2012. PMID: 23205633.
7. Deneve JL, Choi J, Gonzalez RJ, Conley AP, Stewart S, Han D, Werner P, Chaudhry TA, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma. Cardiovasc Intervent Radiol 35(6):1480-7, 12/2012. e-Pub 6/2012. PMID: 22699779.
8. Finkelstein SE, Fishman M, Conley AP, Gabrilovich D, Antonia S, Chiappori A. Cellular immunotherapy for soft tissue sarcomas. Immunotherapy 4(3):283-90, 3/2012. PMID: 22401634.
9. Reynoso D, Nolden LK, Yang D, Dumont SN, Conley AP, Zhou K, Wang WL, Duensing A, Trent J. Synergistic Induction of Apoptosis by the Bcl-2 Inhibitor ABT-737 and Imatinib Mesylate in Gastrointestinal Stromal Tumor Cells. Mol Oncol 5(1):93-104, 2011.
10. Dayyani F, Conley AP, Strom SS, Stevenson W, Cortes JE, Borthakur G, Faderl S, O'Brien S, Pierce S, Kantarjian H, Garcia-Manero G. Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer 116(9):2174-9, 5/2010. PMID: 20162709.
11. Wang WL, Conley AP, Reynoso D, Nolden LK, Lazar A, George S, Trent J. Mechanisms of Resistance to Imatinib and Sunitinib in Gastrointestinal Stromal Tumor. Cancer Chemother Pharmacol 67. e-Pub 1/2010.
12. Conley AP, Trent J, Zhang W. Recent progress in the genomics of soft tissue sarcomas. Curr Opin Oncol 20(4):395-9, 7/2008. PMID: 18525334.
13. Conley AP, Koplin S, Caracciolo J, Reed D, Webber NP, Attia S. Dramatic response to pazopanib in a patient with metastatic malignant granular cell tumor. J Clin Oncol. Submitted.
14. Conley A, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ. Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrent in gastrointestinal stromal tumor patients - a chart extract-based approach. J Gastrointest Cancer. Submitted.

Invited Articles

1. Conley AP. Risk of recurent gastrointestinal stromal tumors. Communityn Oncology. In Press.
2. Conley AP, Benjamin RS. Historic Perspective and Impact of GIST: A Model for Personalized Cancer. Cancer Foundations of Clinical Cancer Research 9(1):24-26, 2010.
3. Conley AP, Stevenson W, Garcia-Manero G. Review of the Response Criteria for Myelodysplastic Syndrome. European Haematology:30-31, 2007.

Abstracts

1. Reynoso D, Conley AP, Trent JC. Synergism of ABT-747 and Imatinib for Apoptosis Induction. AACR, 2010.
2. Conley AP, Araujo D, Ludwig J, Ravi V, Samuels BL, Choi H, Thall PF, Patel S, Benjamin R, Trent J. A Randomized Phase II Study of Perifosine (P) Plus Imatinib for Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST). J Clin Oncol 27(15s) (#10563), 2009.
3. Conley AP, Araujo D, Ludwig J, Ravi V, Samuels BL, Choi H, Patel S, Benjamin R, Trent J. A Randomized Phase II Study of Perifosine (P) Plus Imatinib for Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST). Proc Connective Tissue Oncol Soc (#15:39473), 2009.
4. Conley AP, Reynoso D, Cogdell D, Hu L, Nolden L, Zhang W, Benjamin R, Trent J. Differential Expression of MicroRNA After Imatinib in GIST. Proc Connective Tissue Oncol Soc (#15:39462), 2009.
5. Conley A, Stevenson W, Pierce S, Cortes J, O'Brien S, Ravandi F, Kantarjian H, Garcia-Manero G. Cause of Death in Patients with Lower-Risk Myelodysplastic Syndrome (MDS). J Clin Oncol 26 (#7096), 2008.
6. Dayyani F, Conley AP, Pierce SA, Strom SS, Stevenson W, Borthakur G, Kantarjian HM, Garcia-Manero G. Disease-Related Mortality in Patients with Lower-Risk Myelodysplastic Syndrome (MDS). American Society of Hematology Meeting Book, 2008.
7. Conley A, Manns M, Hall T. Obstructive Jaundice as a Result of Pancreatic Lymphoma. Associates Day American College of Physicians, 2007.
8. Conley A. Effect of Hyperbaric Oxygen in NIDDM Fibroblasts Versus Normal Fibroblasts. UTMB Student Research Poster Session, 2001.
9. Dumont SN, Araujo DS, Dumont AG, Conley AP, Reynoso DR, Munsell MF, Raymond K, Patel S, Benjamin RS, Trent JC. Adult Rhabdomyosarcoma: 239 Patients Followed at MD Anderson Cancer Center. CTOS. Submitted.
10. Park MS, Patel SR, Trent JC, Wang WL, Conley AP. Multidisciplinary Management of Patients with Primary Pulmonary Artery Sarcoma (PPAS). ASCO (#e20501). Submitted.

Book Chapters

1. Conley, AP, Park MS, Trent J, Patel S. Chapter 40: Soft-Tissue and Bone Sarcomas. In: The MD Anderson Manual of Medical Oncology. McGraw Hill Medical: New York. In Press.

Grant & Contract Support

Title: Differential MicroRNA Expression and Positron Emission Tomography in Gastrointestinal Stromal Tumors (GIST) After Treatment with Imatinib
Funding Source: American Society of Clinical Oncology (ASCO)
Role: Principal Investigator
Duration: 7/1/2010 - 7/31/2011
 
Title: MicroRNA Regulation of Aberrant KIT Signaling in Gastrointestinal Stromal Tumors (GIST)
Funding Source: GIST Cancer Research
Role: Co-Principal Investigator
Principal Investigator: Jonathan Trent, MD., Ph.D.
Duration: 8/1/2009

Last updated: 3/7/2014